NCT/Study#
N/A /
2021-0081
Outcomes of Anti-CD19 Chimeric Antigen Receptor (CAR) T-cell Patients: Real World Experience in Lymphoma Patients
DISEASE GROUP:
Lymphoma
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
